Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Urologie (Heidelberg, Germany)|April 7, 2025
[Making prostate cancer research accessible: chatGPT-4 as a tool to enhance lay communication]Maximilian Haas, Veronika Saberi, Christopher Gossler, et al.Journal of Medical Internet Research|November 19, 2025
Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance EvaluationEmily Rinderknecht, Simon U Engelmann, Veronika Saberi, et al.Urologic Oncology|February 21, 2026
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective studyEmily Rinderknecht, Gloria Bielstein, Richard Cathomas, et al.Current Oncology (Toronto, Ont.)|November 26, 2024
Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative StudyEmily Rinderknecht, Dominik von Winning, Anton Kravchuk, et al.European Urology Oncology|December 11, 2025
Benchmarking Large Language Models Against Multidisciplinary Tumor Boards in Urological Oncology: Results from the Blinded, Prospective CONCORDIA StudyEmily Rinderknecht, Maximilian Haas, Marco J Schnabel, et al.European Urology Open Science|July 23, 2025
Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS ProjectThomas Hilser, Jozefina Casuscelli, Can Aydogdu, et al.Cancer Immunology, Immunotherapy : CII|July 12, 2026
Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS)Stefanie Zschäbitz, Irfan Bhatti, Jozefina Casuscelli, et al.Pageof 2